PVT1 and ovarian carcinoma: Hence, to evaluate the clinical significance of PVT1 expression changes alone, we conducted Kaplan–Meier survival analysis using KM plotter (Gyorffy et al, 2012) in TCGA datasets that included all ovarian cancer patients with a best cutoff analysis (Nagy et al, 2018).